6th Annual
Advances in Immuno-Oncology Congress
May 2021 | London, UK

An outstanding and comprehensive programme showcasing the key therapeutic strategies and technological advances impacting this marketplace

The Advances in Immuno-Oncology Congress includes...

Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools

Over 60 presentations, case studies and panel discussions focussed on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research

PLUS interactive opportunities including:

  • Workshop on Accelerating the Treatment & Response Rate of Cancer Immunotherapies
  • 6 roundtable discussions on key industry growth areas within immuno-oncology

Last Year's Agenda at a Glance

Day One

  • Discovery of Immuno-Oncology Therapies: Inhibitory Pathway & Cell-Based Approaches
  • Translational Immuno-Oncology
  • Personalised Therapies for Immuno-Oncology

Day Two

  • Discovery of Immuno-Oncology Therapies: Antibody and Virus-Based Approaches
  • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
  • Clinical Research & Trials in Immuno- Oncology

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure

Calling all Immunologists!

With a key priority in the IO industry centring around developing effective combination therapies, we are currently preparing a detailed market survey to provide the community with insights from leading experts into their strategies for this, the technologies they require and any bottlenecks.

Have your say in our Immuno-Oncology Market Survey & win an iPad Mini 4!